On Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Orphan diseases
- Congenital disorders of glycosylation
- Some basic facts and definitions
- The challenges of post-translational modification
- Sugar-amino acid linkages of glycoproteins
- N-glycosylation
- Glycogenes
- N-glycan synthesis is an extra-cellular event (1)
- N-glycan synthesis is an extra-cellular event (2)
- Glycoprotein functions
- A typical protein bound N-linked glycan
- Linear and branched isomers of a hexasaccharide
- Jaeken-Stibler collaboration
- 3-year-old CDG patient
- Clinical features of CDG patients
- Undersialylation of serum transferrin
- Classification of CDGs using old nomenclature
- Type I congenital disorders of glycosylation
- Dolichol-linked precursor oligosaccharide (1)
- Dolichol-linked precursor oligosaccharide (2)
- Dolichol-linked precursor oligosaccharide (3)
- En bloc transfer to protein
- OST needs full Glc3Man9GlcNAc2 moiety to act
- Serum transferrin in CDG type I patients
- Isoelectric focusing (IEF) of serum transferrin
- Dolichol-linked precursor oligosaccharide (4)
- Dolichol-linked 14 monomer oligosaccharide
- Mutations in the alg loci
- Different CDG mutations
- CDG-Ia
- Oral mannose by-passes the CDG-Ib block
- Type II congenital disorders of glycosylation
- N-glycan processing
- The Golgi is the main site of glycosilation
- First CDG patient with an identified gene defect (1)
- First CDG patient with an identified gene defect (2)
- Congenital disorders of glycosylation type 2 (1)
- N-glycan synthesis pathway in ER-Golgi
- Congenital disorders of glycosylation type 2 (2)
- N-glycan synthesis pathway in Golgi
- Conserved oligomeric Golgi complex
- A summary of the CDG mutations
- Mice models for CDG mutations (1)
- Mice models for CDG mutations (2)
- Summary (Jaak Jaeken)
- CDG genes discovered
- Summary (Hudson Freeze)
- Many thanks for your attention
Topics Covered
- Orphan diseases
- Post-translational modifications
- Definition of N-glycosylation
- The significance of the extra-cellular location of N-glycosylation
- Diagnosis and clinical features of patients with Congenital Disorders of Glycosylation (CDGs)
- The biochemical mechanisms of normal N-glycosylation
- Description of 47 mutations in the N-glycosylation pathway that result in CDG
Links
Series:
Categories:
Talk Citation
Schachter, H. (2012, November 27). Congenital disorders of N-glycosylation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 15, 2025, from https://doi.org/10.69645/JTAL4626.Export Citation (RIS)
Publication History
- Published on November 27, 2012
Financial Disclosures
- Prof. Harry Schachter has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.